If we look at the company completely without covid, for a new ipo the growth is not bad at all.
But since atomo ipo is at the time when covid just started, the sp jump to an usual high level due to fomo. And adjust downward with out events like FDA approval to keep the FOMO alive.
The company is growing fast, just that we are now have much higher expectations because of Covid.
I see the fundamental is strong and long term risk is low.
AT1 FY21 - General Discussion + FA, page-892
-
- There are more pages in this discussion • 1,542 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
